This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 686 p10; 801085736
Reference
Scottish Medicines Consortium. SMC advice: aripiprazole (Abilify); caffeine citrate (Peyona); etravirine (Intelence); lixisenatide (Lyxumia); medroxyprogesterone acetate (Sayana Press); ocriplasmin (Jetrea); raltegravir (Isentress); rifaximin (Targaxan); rituximab (Mabthera); tenofovir disoproxil (Viread). Internet Document : 9 Sep 2013. Available from: URL: http://www.scottishmedicines.org.uk
Rights and permissions
About this article
Cite this article
Latest advice from the SMC. PharmacoEcon Outcomes News 687, 11 (2013). https://doi.org/10.1007/s40274-013-0735-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0735-5